FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126795314> ?p ?o ?g. }

• W3126795314 endingPage "e045140" @default.
• W3126795314 startingPage "e045140" @default.
• W3126795314 abstract "Objectives To study how patient groups that accept pharmaceutical industry money perceive and manage the risk of undue influence from their sponsors. Design Empirical ethics approach using a qualitative interview study. Setting The Australian patient group sector. Participants 27 participants from 23 patient groups, purposively recruited for diversity of group characteristics (degree of pharmaceutical industry funding, health focus, location) and participant role (staff, board members). Analysis Interview data were transcribed and read repeatedly to identify concepts and patterns in the data. These were grouped into conceptual categories that described and explained the findings. We used an inductive analytical approach to identify important themes and concepts in the data. Results Participants in this study described how the patient group sector receives pressure from pharmaceutical company funders to act in ways that prioritise company interests. Groups worked to try and protect their credibility and ability to act in ways of their own choosing using practical rules or ‘lines in the sand’ about industry funding activities. They were grouped around the dominant topics of: sponsor exclusivity, brand marketing, agenda setting, advocacy and content of group activities. Lines in the sand were largely experience-driven and ethically informed; they varied between groups. There was also variable transparency among groups about financial interactions with pharmaceutical companies. Conclusions It is important to know about patient group practices around pharmaceutical industry funders as this allows public scrutiny about the adequacy of such practices. Inadequate strategies may mean that funders can influence patient groups activities in ways that do not necessarily prioritise the interests of members. We found that groups differed in their approach, with little independent external guidance to inform responses to commonly encountered types of influence. Inadequate transparency limits the ability of the public to make informed assessments about the risk of bias over the activities of groups that accept industry funding." @default.
• W3126795314 created "2021-02-15" @default.
• W3126795314 creator A5000765105 @default.
• W3126795314 creator A5003192930 @default.
• W3126795314 creator A5004372791 @default.
• W3126795314 creator A5009149308 @default.
• W3126795314 creator A5040792716 @default.
• W3126795314 date "2021-02-01" @default.
• W3126795314 modified "2023-10-04" @default.
• W3126795314 title "‘Lines in the sand’: an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders" @default.
• W3126795314 cites W1503851300 @default.
• W3126795314 cites W1548578164 @default.
• W3126795314 cites W1714980748 @default.
• W3126795314 cites W1964644957 @default.
• W3126795314 cites W1967676526 @default.
• W3126795314 cites W1972089646 @default.
• W3126795314 cites W1979525371 @default.
• W3126795314 cites W1980565555 @default.
• W3126795314 cites W1980806410 @default.
• W3126795314 cites W2013418879 @default.
• W3126795314 cites W2038556540 @default.
• W3126795314 cites W2041926342 @default.
• W3126795314 cites W2044158076 @default.
• W3126795314 cites W2047674919 @default.
• W3126795314 cites W2111464092 @default.
• W3126795314 cites W2112937163 @default.
• W3126795314 cites W2125369282 @default.
• W3126795314 cites W2138664283 @default.
• W3126795314 cites W2155750557 @default.
• W3126795314 cites W2437487086 @default.
• W3126795314 cites W2465483973 @default.
• W3126795314 cites W2580960130 @default.
• W3126795314 cites W2581136646 @default.
• W3126795314 cites W2582326098 @default.
• W3126795314 cites W2592719167 @default.
• W3126795314 cites W2884801666 @default.
• W3126795314 cites W2905018650 @default.
• W3126795314 cites W2909268998 @default.
• W3126795314 cites W2913571101 @default.
• W3126795314 cites W2945710606 @default.
• W3126795314 cites W2954062887 @default.
• W3126795314 cites W2957460692 @default.
• W3126795314 cites W2996293517 @default.
• W3126795314 cites W3001214788 @default.
• W3126795314 cites W3106879361 @default.
• W3126795314 cites W3122308642 @default.
• W3126795314 cites W4246820379 @default.
• W3126795314 cites W4301522431 @default.
• W3126795314 doi "https://doi.org/10.1136/bmjopen-2020-045140" @default.
• W3126795314 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7875302" @default.
• W3126795314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33563626" @default.
• W3126795314 hasPublicationYear "2021" @default.
• W3126795314 type Work @default.
• W3126795314 sameAs 3126795314 @default.
• W3126795314 citedByCount "6" @default.
• W3126795314 countsByYear W31267953142021 @default.
• W3126795314 countsByYear W31267953142022 @default.
• W3126795314 countsByYear W31267953142023 @default.
• W3126795314 crossrefType "journal-article" @default.
• W3126795314 hasAuthorship W3126795314A5000765105 @default.
• W3126795314 hasAuthorship W3126795314A5003192930 @default.
• W3126795314 hasAuthorship W3126795314A5004372791 @default.
• W3126795314 hasAuthorship W3126795314A5009149308 @default.
• W3126795314 hasAuthorship W3126795314A5040792716 @default.
• W3126795314 hasBestOaLocation W31267953141 @default.
• W3126795314 hasConcept C10138342 @default.
• W3126795314 hasConcept C119857082 @default.
• W3126795314 hasConcept C144024400 @default.
• W3126795314 hasConcept C144133560 @default.
• W3126795314 hasConcept C159110408 @default.
• W3126795314 hasConcept C162853370 @default.
• W3126795314 hasConcept C17744445 @default.
• W3126795314 hasConcept C190248442 @default.
• W3126795314 hasConcept C199539241 @default.
• W3126795314 hasConcept C2776050585 @default.
• W3126795314 hasConcept C2777276634 @default.
• W3126795314 hasConcept C2779652045 @default.
• W3126795314 hasConcept C2780224610 @default.
• W3126795314 hasConcept C2780233690 @default.
• W3126795314 hasConcept C36289849 @default.
• W3126795314 hasConcept C39549134 @default.
• W3126795314 hasConcept C41008148 @default.
• W3126795314 hasConcept C509550671 @default.
• W3126795314 hasConcept C56995899 @default.
• W3126795314 hasConcept C71924100 @default.
• W3126795314 hasConcept C87156501 @default.
• W3126795314 hasConcept C98274493 @default.
• W3126795314 hasConceptScore W3126795314C10138342 @default.
• W3126795314 hasConceptScore W3126795314C119857082 @default.
• W3126795314 hasConceptScore W3126795314C144024400 @default.
• W3126795314 hasConceptScore W3126795314C144133560 @default.
• W3126795314 hasConceptScore W3126795314C159110408 @default.
• W3126795314 hasConceptScore W3126795314C162853370 @default.
• W3126795314 hasConceptScore W3126795314C17744445 @default.
• W3126795314 hasConceptScore W3126795314C190248442 @default.
• W3126795314 hasConceptScore W3126795314C199539241 @default.
• W3126795314 hasConceptScore W3126795314C2776050585 @default.
• W3126795314 hasConceptScore W3126795314C2777276634 @default.

• next